Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125924591 | 12592459 | 1 | I | 2016 | 20160706 | 20160726 | 20160726 | PER | US-TEVA-676477USA | TEVA | 0.00 | F | Y | 95.79000 | KG | 20160726 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125924591 | 12592459 | 1 | PS | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | Y | 77083 | |||||||||||
| 125924591 | 12592459 | 2 | SS | XELJANZ | TOFACITINIB CITRATE | 1 | 10 MILLIGRAM DAILY; | M73569 | 0 | 5 | MG | BID | |||||||
| 125924591 | 12592459 | 3 | SS | ENBREL | ETANERCEPT | 1 | Y | 0 | |||||||||||
| 125924591 | 12592459 | 4 | SS | ETANERCEPT | ETANERCEPT | 1 | Y | 0 | |||||||||||
| 125924591 | 12592459 | 5 | SS | ARAVA | LEFLUNOMIDE | 1 | Y | 0 | |||||||||||
| 125924591 | 12592459 | 6 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | Y | 0 | |||||||||||
| 125924591 | 12592459 | 7 | C | NAPROXEN. | NAPROXEN | 1 | 1000 MILLIGRAM DAILY; | 0 | 500 | MG | BID | ||||||||
| 125924591 | 12592459 | 8 | C | PANTOPRAZOLE SODIUM. | PANTOPRAZOLE SODIUM | 1 | 40 MILLIGRAM DAILY; | 0 | 40 | MG | QD | ||||||||
| 125924591 | 12592459 | 9 | C | Herbalife | 2 | 0 | |||||||||||||
| 125924591 | 12592459 | 10 | C | DOXYCYCLINE HYCLATE. | DOXYCYCLINE HYCLATE | 1 | 200 MILLIGRAM DAILY; | 0 | 100 | MG | TABLET | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125924591 | 12592459 | 1 | Rheumatoid arthritis |
| 125924591 | 12592459 | 2 | Rheumatoid arthritis |
| 125924591 | 12592459 | 3 | Rheumatoid arthritis |
| 125924591 | 12592459 | 4 | Rheumatoid arthritis |
| 125924591 | 12592459 | 5 | Rheumatoid arthritis |
| 125924591 | 12592459 | 6 | Rheumatoid arthritis |
| 125924591 | 12592459 | 7 | Joint swelling |
| 125924591 | 12592459 | 8 | Gastritis |
| 125924591 | 12592459 | 9 | Phytotherapy |
| 125924591 | 12592459 | 10 | Eye disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125924591 | 12592459 | HO |
| 125924591 | 12592459 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125924591 | 12592459 | Abdominal pain upper | |
| 125924591 | 12592459 | Adverse event | |
| 125924591 | 12592459 | Anxiety | |
| 125924591 | 12592459 | Drug hypersensitivity | |
| 125924591 | 12592459 | Dry eye | |
| 125924591 | 12592459 | Gait disturbance | |
| 125924591 | 12592459 | Gastrointestinal disorder | |
| 125924591 | 12592459 | Nervousness | |
| 125924591 | 12592459 | Rash | |
| 125924591 | 12592459 | Rheumatoid arthritis | |
| 125924591 | 12592459 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125924591 | 12592459 | 1 | 2012 | 2014 | 0 | |
| 125924591 | 12592459 | 2 | 2016 | 0 | ||
| 125924591 | 12592459 | 3 | 2012 | 2014 | 0 | |
| 125924591 | 12592459 | 4 | 2012 | 2014 | 0 | |
| 125924591 | 12592459 | 5 | 2012 | 2014 | 0 | |
| 125924591 | 12592459 | 6 | 2012 | 2014 | 0 | |
| 125924591 | 12592459 | 7 | 201506 | 0 | ||
| 125924591 | 12592459 | 8 | 2013 | 0 | ||
| 125924591 | 12592459 | 10 | 2016 | 0 |